Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

1. Renal Endometriosis: The Case of an Endometrial Implant Mimicking a Renal Mass

Renal Endometriosis: The Case of an Endometrial Implant Mimicking a Renal Mass 30393762 2018 11 14 2379-9889 4 1 2018 Journal of endourology case reports J Endourol Case Rep Renal Endometriosis: The Case of an Endometrial Implant Mimicking a Renal Mass. 176-178 10.1089/cren.2018.0070 Background: Endometriosis is a multifactorial benign disorder characterized by the abnormal presence of endometrial tissue in an extraendometrial site. Although extrapelvic endometriosis is uncommon, symptomatic (...) : This case of renal endometriosis highlights how this benign disease process can mimic several more sinister urologic processes. Badri Anand V AV Department of Urology, Temple University Hospital, Philadelphia, Pennsylvania. Jennings Rachel R Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania. Patel Pavan P Cooper Medical School of Rowan University, Camden, New Jersey. Eun Daniel D DD Department of Urology, Temple University Hospital, Philadelphia, Pennsylvania. eng Journal

Journal of endourology case reports2018 Full Text: Link to full Text with Trip Pro

2. MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis – A Critical Appraisal

MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis – A Critical Appraisal 30255164 2018 11 14 2509-596X 4 3 2018 Sep Ultrasound international open Ultrasound Int Open MRI-Ultrasound Fusion Imaging for Diagnosis of Deep Infiltrating Endometriosis - A Critical Appraisal. E85-E90 10.1055/a-0647-1575 It was the aim of our study to evaluate this procedure using pelvic anatomical landmarks in order to assess the accuracy of fusion imaging and to critically evaluate (...) the applicability in daily practice. In a prospective, single center study, 10 patients with clinical signs of deep infiltrating endometriosis (DIE) were selected. We measured the distance between the landmark organ and the target shown by the software system (measurement 1). Measurement 2 depicts the distance between the landmark and the nearest calibration point. The calibration inaccuracy was measured as a third type of measurement (measurement 3). Measurement 1: the average distance between the organ

Ultrasound international open2018 Full Text: Link to full Text with Trip Pro

3. Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis

Elagolix sodium (Orilissa) - For the management of moderate to severe pain associated with endometriosis Drug Approval Package: Orilissa (elagolix sodium) U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: Orilissa (elagolix sodium) Company: AbbVie Inc. Application Number: 210450 Approval Date: 07/23/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF

FDA - Drug Approval Package2018

4. Endometriosis

Endometriosis Top results for endometriosis - Trip Database or use your Google+ account Turning Research Into Practice My query is: English Français Deutsch Čeština Español Magyar Svenska ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box (...) and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for endometriosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical

Trip Latest and Greatest2018

5. Elagolix for Treating Endometriosis

Elagolix for Treating Endometriosis ©Institute for Clinical and Economic Review, 2018 Elagolix for Treating Endometriosis Final Evidence Report August 03, 2018 Prepared for ©Institute for Clinical and Economic Review, 2018 Page i Final Evidence Report– Elagolix for Treating Endometriosis ICER Staff/Consultants University of Colorado Skaggs School of Pharmacy Modeling Group* Steven J. Atlas, MD, MPH Director, Primary Care Research and Quality Improvement Network Massachusetts General Hospital (...) and Economic Review, 2018 Page ii Final Evidence Report– Elagolix for Treating Endometriosis About ICER The Institute for Clinical and Economic Review (ICER) is an independent non-profit research organization that evaluates medical evidence and convenes public deliberative bodies to help stakeholders interpret and apply evidence to improve patient outcomes and control costs. Through all its work, ICER seeks to help create a future in which collaborative efforts to move evidence into action provide

California Technology Assessment Forum2018

6. Inhibitory effect of traditional Korean medicine on the recurrent endometriosis after laparoscopic excision: a case report

Inhibitory effect of traditional Korean medicine on the recurrent endometriosis after laparoscopic excision: a case report 30271719 2018 11 14 2213-4220 7 3 2018 Sep Integrative medicine research Integr Med Res Inhibitory effect of traditional Korean medicine on the recurrent endometriosis after laparoscopic excision: a case report. 296-301 10.1016/j.imr.2018.07.003 Endometriosis is a common benign gynecologic tumor, and it can destroy a patient's life. Surgery and hormone therapy (...) are established therapies for endometriosis. However, there are many cases of recurrent endometriosis after conventional therapies. This report presents a case of a patient who has repetitive recurrence of endometriosis after laparoscopic excision and hormone therapy. A 32-years-old female patient first had laparoscopic surgery to remove endometriosis in 2011. The disease recurred two more times after the first excision. Hormone therapy by dienogest and two more laparoscopic surgeries were done in 2012

Integrative medicine research2018 Full Text: Link to full Text with Trip Pro

7. Elagolix for Treating Endometriosis

Elagolix for Treating Endometriosis ©Institute for Clinical and Economic Review, 2018 Elagolix for Treating Endometriosis Evidence Report June 15, 2018 Prepared for ©Institute for Clinical and Economic Review, 2018 Page i Evidence Report– Elagolix for Treating Endometriosis ICER Staff/Consultants University of Colorado Skaggs School of Pharmacy Modeling Group* Steven J. Atlas, MD, MPH Director, Primary Care Research and Quality Improvement Network Massachusetts General Hospital Geri Cramer, BSN (...) , 2018 Page ii Evidence Report– Elagolix for Treating Endometriosis About ICER The Institute for Clinical and Economic Review (ICER) is an independent non-profit research organization that evaluates medical evidence and convenes public deliberative bodies to help stakeholders interpret and apply evidence to improve patient outcomes and control costs. Through all its work, ICER seeks to help create a future in which collaborative efforts to move evidence into action provide the foundation for a more

California Technology Assessment Forum2018

8. Notch-1 Signaling Activation and Progesterone Receptor Expression in Ectopic Lesions of Women With Endometriosis

Notch-1 Signaling Activation and Progesterone Receptor Expression in Ectopic Lesions of Women With Endometriosis 30151432 2018 11 14 2472-1972 2 7 2018 Jul 01 Journal of the Endocrine Society J Endocr Soc Notch-1 Signaling Activation and Progesterone Receptor Expression in Ectopic Lesions of Women With Endometriosis. 765-778 10.1210/js.2018-00007 Progesterone (P) resistance is a hallmark of endometriosis, but the underlying mechanism(s) for loss of P sensitivity leading to lesion establishment (...) remains poorly understood. To evaluate the association between Notch-1 signaling activation and P resistance in the progression of endometriosis. Case control study; archived formalin-fixed, paraffin-embedded tissues. University hospitals (United States, Taiwan). Women with endometriosis; human endometrial stromal cell line (HESC). Eutopic endometria (EU) and ectopic lesions (ECs) were collected from surgically diagnosed patients. Archived tissue sections of EU and ECs were identified. HESCs were

Journal of the Endocrine Society2018 Full Text: Link to full Text with Trip Pro

9. Oral contraceptives for pain associated with endometriosis.

Oral contraceptives for pain associated with endometriosis. BACKGROUND: Endometriosis is a common gynaecological condition which affects many women of reproductive age worldwide and is a major cause of pain and infertility. The combined oral contraceptive pill (COCP) is widely used to treat pain occurring as a result of endometriosis, although the evidence for its efficacy is limited. OBJECTIVES: To determine the effectiveness, safety and cost-effectiveness of oral contraceptive preparations (...) in the treatment of painful symptoms ascribed to the diagnosis of laparoscopically proven endometriosis. SEARCH METHODS: We searched the following from inception to 19 October 2017: the Cochrane Gynaecology and Fertility Group Specialised Register of Controlled Trials, the Cochrane CENTRAL Register of Studies Online (CRSO), MEDLINE, Embase, PsycINFO, CINAHL (Cumulative Index to Nursing and Allied Health Literature), and the trial registers ClinicalTrials.gov and the World Health Organization Clinical Trials

Cochrane2018

10. Recommendations for surgical treatment of endometriosis. Part 1: Ovarian Endometrioma

Recommendations for surgical treatment of endometriosis. Part 1: Ovarian Endometrioma Recommendations for the Surgical Treatment of Endometriosis. Part 1: Ovarian Endometrioma†‡¶ | Human Reproduction Open | Oxford Academic We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter (...) search input Article Navigation Close mobile search navigation Article navigation 2017 Article Contents Article Navigation Recommendations for the Surgical Treatment of Endometriosis. Part 1: Ovarian Endometrioma Working group of ESGE, ESHRE and WES Search for other works by this author on: Ertan Saridogan Institute for Women's Health , University College Hospital , Reproductive Medicine Unit, Elizabeth Garrett Anderson Wing, London NW1 2BU , UK Correspondence address. Institute for Women's Health

European Society of Human Reproduction and Embryology2018

11. Endometriosis

Endometriosis Endometriosis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Endometriosis Last reviewed: August 2018 Last updated: July 2018 Summary Chronic inflammatory condition defined by endometrial stroma and glands found outside of the uterine cavity. The most common sites affected are the pelvic peritoneum and ovaries. May present incidentally in asymptomatic patients, or more commonly in women of reproductive (...) ovarian hyper-stimulation and IVF may be considered for patients with sub-fertility. Individualised care for patients with pelvic pain should incorporate a multi-disciplinary evaluation and treatment plan that focuses on limiting the risk of recurrence and improving quality of life. Definition Endometriosis is defined as the presence of endometrial glands and stroma outside the endometrial cavity and uterine musculature. Surgical appearance varies significantly from superficial blebs to infiltrating

BMJ Best Practice2018

12. Endometriosis: A Rare Cause of Large Bowel Obstruction

Endometriosis: A Rare Cause of Large Bowel Obstruction 29662933 2018 11 14 2341-4545 25 2 2018 Mar GE Portuguese journal of gastroenterology GE Port J Gastroenterol Endometriosis: A Rare Cause of Large Bowel Obstruction. 86-90 10.1159/000480707 Large bowel obstruction can result in significant morbidity and mortality, especially in cases of acute complete obstruction. There are many possible causes, the most common in adults being colorectal cancer. Endometriosis is a benign disease (...) , and the most affected extragenital location is the bowel, especially the rectosigmoid junction. However, transmural involvement and acute occlusion are very rare events. We report an exceptional case of acute large bowel obstruction as the initial presentation of endometriosis. The differential diagnosis of colorectal carcinoma may be challenging, and this case emphasizes the need to consider intestinal endometriosis in females at a fertile age presenting with gastrointestinal symptoms and an intestinal

GE Portuguese journal of gastroenterology2017 Full Text: Link to full Text with Trip Pro

13. Endometriosis: diagnosis and management

Endometriosis: diagnosis and management Endometriosis: diagnosis and Endometriosis: diagnosis and management management NICE guideline Published: 6 September 2017 nice.org.uk/guidance/ng73 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When (...) with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Endometriosis: diagnosis and management (NG73) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 25Contents Contents Overview 4 Who is it for? 4 Recommendations 5 1.1

National Institute for Health and Clinical Excellence - Clinical Guidelines2017

14. History of breast feeding and risk of incident endometriosis: prospective cohort study.

History of breast feeding and risk of incident endometriosis: prospective cohort study. Objective To investigate the association between lifetime breast feeding, exclusive breast feeding, postpartum amenorrhea, and incidence of endometriosis among parous women. Design Prospective cohort study. Setting Nurses' Health Study II, 1989-2011. Participants 72 394women who reported having one or more pregnancies that lasted at least six months, 3296 of whom had laparoscopically confirmed endometriosis (...) . For each pregnancy, women reported duration of total breast feeding, exclusive breast feeding, and postpartum amenorrhea. Main outcome measures Incident self reported laparoscopically confirmed endometriosis (96% concordance with medical record) in parous women. Multivariable Cox proportional hazard models were used to calculate hazard ratios and 95% confidence intervals for diagnosis of endometriosis. Results Duration of total and exclusive breast feeding was significantly associated

BMJ2017 Full Text: Link to full Text with Trip Pro

15. Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus? Assessment according to §137h Social Code Book V

Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus? Assessment according to §137h Social Code Book V 1 Translation of the executive summary of the assessment according to §137h Social Code Book (SGB) V Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus (Version 1.0; Status: 30 January 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text (...) is absolutely authoritative and legally binding. Executive Summary IQWiG Reports – Commission No. H16-02A Ultrasound-guided high- intensity focused ultrasound therapy for uterine endometriosis 1 Executive summary of assessment H16-02A according to §137h SGB V Version 1.0 USgHIFU for uterine endometriosis 30 January 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Ultrasound-guided

Institute for Quality and Efficiency in Healthcare (IQWiG)2017

16. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist.

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. Background Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist, produced partial to nearly full estrogen suppression in previous studies. Methods We performed two similar, double-blind, randomized, 6-month phase 3 trials (Elaris Endometriosis I and II [EM-I and EM-II]) to evaluate (...) the effects of two doses of elagolix - 150 mg once daily (lower-dose group) and 200 mg twice daily (higher-dose group) - as compared with placebo in women with surgically diagnosed endometriosis and moderate or severe endometriosis-associated pain. The two primary efficacy end points were the proportion of women who had a clinical response with respect to dysmenorrhea and the proportion who had a clinical response with respect to nonmenstrual pelvic pain at 3 months. Each of these end points was measured

NEJM2017

17. Cancer-Associated Mutations in Endometriosis without Cancer.

Cancer-Associated Mutations in Endometriosis without Cancer. BACKGROUND: Endometriosis, defined as the presence of ectopic endometrial stroma and epithelium, affects approximately 10% of reproductive-age women and can cause pelvic pain and infertility. Endometriotic lesions are considered to be benign inflammatory lesions but have cancerlike features such as local invasion and resistance to apoptosis. METHODS: We analyzed deeply infiltrating endometriotic lesions from 27 patients by means (...) →T and c.35G→C, and another carried identical KRAS c.35G→A mutations in three distinct lesions. CONCLUSIONS: We found that lesions in deep infiltrating endometriosis, which are associated with virtually no risk of malignant transformation, harbor somatic cancer driver mutations. Ten of 39 deep infiltrating lesions (26%) carried driver mutations; all the tested somatic mutations appeared to be confined to the epithelial compartment of endometriotic lesions.

NEJM2017 Full Text: Link to full Text with Trip Pro

18. Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to õ137h Social Code Book V

Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to õ137h Social Code Book V Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus: Bewertungen gemäß § 137h SGB V; Auftrag: H16-02A [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V] Sonografiegesteuerte hochfokussierte Ultraschalltherapie bei der Endometriose des Uterus (...) : Bewertungen gemäß § 137h SGB V; Auftrag: H16-02A [Ultrasound-guided high-intensity focused ultrasound for endometriosis of the uterus: Assessment according to §137h Social Code Book V] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im

Health Technology Assessment (HTA) Database.2017

19. Abdominal wall endometriosis: differentiation from other masses using CT features

Abdominal wall endometriosis: differentiation from other masses using CT features 28004137 2018 04 04 2018 11 13 2366-0058 42 5 2017 05 Abdominal radiology (New York) Abdom Radiol (NY) Abdominal wall endometriosis: differentiation from other masses using CT features. 1517-1523 10.1007/s00261-016-0998-y To assess the utility of morphologic and quantitative CT features in differentiating abdominal wall endometriosis (AWE) from other masses of the abdominal wall. Retrospective IRB-approved study (...) endometriosis. The other most common diagnoses included adenocarcinoma NOS (21%; 22/105), desmoid (14.3%; 15/105), and leiomyosarcoma (8.6%; 9/105). CT features significantly associated with endometriosis for both readers were location below the umbilicus (P = 0.0188), homogeneous density (P = 0.0188), and presence of linear infiltration irradiating peripherally from a central soft tissue nodule (i.e., "gorgon" sign) (P < 0.0001). The highest combined sensitivity (0.69, 95% CI: 0.48-0.86) and specificity

Abdominal radiology (New York)2017 Full Text: Link to full Text with Trip Pro

20. The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial

The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial 29264492 2018 11 13 2472-1972 1 4 2017 Apr 01 Journal of the Endocrine Society J Endocr Soc The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial. 359-369 10.1210/js.2017-00053 Resveratrol has been used for the treatment of endometriosis. To compare resveratrol (40 mg/d) with monophasic contraceptive pill (COC) to COC with placebo (...) for the reduction of pain scores. A randomized clinical trial. University Hospital. Women (ages 20 to 50) with laparoscopic diagnosis of endometriosis were eligible for the study. Exclusion criteria: pregnancy, allergy to resveratrol, or contraindications to COC, use of agonists of gonadotropin release hormone or danazol in the last month, or had used depot medroxyprogesterone acetate or Mirena®. Subjects were randomized using a computer-generated randomization list to receive COC for 42 days to be taken

Journal of the Endocrine Society2017 Full Text: Link to full Text with Trip Pro